Literature DB >> 8143377

Update on immunofluorescent testing in bullous diseases and lupus erythematosus.

L E Gately1, L T Nesbitt.   

Abstract

One of the earliest methods for investigating the immunologic basis of disease was the use of immunofluorescence (IF) on skin biopsy specimens and serum. IF can be used to detect immunoglobulins, complement components, and fibrin. In some diseases, the IF findings are disease specific and diagnostic, especially in certain bullous diseases. The use of IF testing has increased with the recent development of the salt split skin technique. The newer IF findings in some well-established immunodermatologic diseases and several recently described diseases are discussed. A brief description of the techniques involved in direct and indirect IF is also presented.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8143377

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  3 in total

1.  Anti-BP180-type mucous membrane pemphigoid: report of two cases.

Authors:  Mayumi Wada; Jun Sato; Masanobu Shindoh; Hideyuki Ujiie; Ken Natsuga; Wataru Nishie; Hiroshi Shimizu; Yoshimasa Kitagawa
Journal:  Odontology       Date:  2014-10-30       Impact factor: 2.634

2.  Bullous lupus erythematosus in a patient with pre-existing dermatomyositis.

Authors:  Joerg Wenzel; Dirk Bokemeyer; Dagmar Wilsmann; Rainer Gerdsen; Thomas Tueting; Manfred Uerlich; Thomas Bieber
Journal:  Rheumatol Int       Date:  2003-07-16       Impact factor: 2.631

3.  Enhanced diagnostic immunofluorescence using biopsies transported in saline.

Authors:  Robert M Vodegel; Marcelus C J M de Jong; Hillegonda J Meijer; Marijn B Weytingh; Hendri H Pas; Marcel F Jonkman
Journal:  BMC Dermatol       Date:  2004-08-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.